Amwill Health Care Ltd
Statement of profit and loss
Figures in ₹ crore, reproduced from the results data files the company filed with BSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.
| ₹ crore | — | vs a year ago | 6M FY26 |
|---|---|---|---|
| Revenue from operations | — | — | 24.29 |
| Other income | — | — | 1.52 |
| Total income | — | — | 25.81 |
| Employee benefit expense | — | — | 4.16 |
| Finance costs | — | — | 0.00 |
| Depreciation & amortisation | — | — | 0.30 |
| Total expenses | — | — | 15.71 |
| Profit before tax | — | — | 10.10 |
| Tax expense | — | — | 2.55 |
| Profit after tax | — | — | 7.55 |
| Total comprehensive income | — | — | — |
| Earnings per share, basic | — | ₹3.77 |
|---|---|---|
| Earnings per share, diluted | — | ₹3.77 |
6M FY26 — from the company’s filing with BSE. Source
Why the dash
Parakho has not ingested this company’s year-ago quarter, so the change column stays empty. A dash means we do not hold the figure — never that it is zero.
Earnings call
Amwill Health Care Ltd has not filed a concall transcript in the last 4 quarters.
Filings
12 shown · 26 published by the exchange
10 Oct 2026
08 Oct 2026
28 Sept 2026
Insider trading25 Sept 2026
14 Aug 2026
Filing14 Aug 2026
14 Aug 2026
08 Aug 2026
08 Aug 2026
Filing23 Jul 2026
23 Jul 2026
Filing22 Jul 2026
BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.
Industry
Healthcare › Pharmaceuticals
Classification as published by BSE.
Companies also in Pharmaceuticals, in alphabetical order
Page generated from filings held to 10 Oct 2026.